Literature DB >> 8273575

Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage.

K D Rainsford1.   

Abstract

Studies in pigs and rats were undertaken to explore further the role of leukotrienes following administration of NSAIDs on the development of gastrointestinal damage. Increased leukotriene C4 production occurred in the gastric circulation in the early stages after administration of a single dose of indomethacin (10 mg/kg i.g.) to pigs. Gastric and intestinal mucosal lesions by NSAIDs were prevented by both prior (2-5 h)+ 0.25 or 0h oral dosing of the 5-lipoxygenase inhibitor, MK-886, but not when only one of these doses was given. These results show the importance of enhanced peptidoleukotriene production in relation to microvascular damage from cyclooxygenase inhibition by NSAIDs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8273575     DOI: 10.1007/bf01972709

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  Evidence for differing leukotriene receptors in gastric mucosa.

Authors:  R G Pendleton; J R Stavorski
Journal:  Eur J Pharmacol       Date:  1986-06-17       Impact factor: 4.432

2.  The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1987-08

Review 3.  Lipid mediators of inflammation in gastric ulcer.

Authors:  J L Wallace
Journal:  Am J Physiol       Date:  1990-01

4.  Ultrastructural observations on the pathogenesis of aspirin-induced gastric erosions.

Authors:  P G Robins
Journal:  Br J Exp Pathol       Date:  1980-10

5.  Leukotrienes C4 and D4 potentiate acid production by isolated rat parietal cells.

Authors:  W Schepp; D Kath; C Tatge; B Zimmerhackl; V Schusdziarra; M Classen
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

6.  Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production.

Authors:  K D Rainsford; C Willis
Journal:  Dig Dis Sci       Date:  1982-07       Impact factor: 3.199

7.  A profile of the gastric ulcerogenic activity of benoxaprofen compared with other nonsteroidal anti-inflammatory drugs in rats, stressed or given alcohol, and in pigs.

Authors:  K D Rainsford
Journal:  Eur J Rheumatol Inflamm       Date:  1982

8.  Identification and isolation of a membrane protein necessary for leukotriene production.

Authors:  D K Miller; J W Gillard; P J Vickers; S Sadowski; C Léveillé; J A Mancini; P Charleson; R A Dixon; A W Ford-Hutchinson; R Fortin
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

  8 in total
  18 in total

Review 1.  [Therapy with nonsteroidal anti-inflammatory drugs].

Authors:  H Bauer; E Märker-Hermann
Journal:  Orthopade       Date:  2003-12       Impact factor: 1.087

2.  Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.

Authors:  F Polito; A Bitto; N Irrera; F Squadrito; C Fazzari; L Minutoli; D Altavilla
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Aspirin treatment and increased generation of cysteinyl leukotrienes in Kawasaki disease.

Authors:  T Shimizu; Y Yamashiro; K Yabuta
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

4.  Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F1 alpha and leukotriene B4 level in relation to gastroenteropathy.

Authors:  A Uçar; S D Sak; M Melli
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

5.  Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome.

Authors:  Markus Werner; Paul M Jordan; Erik Romp; Anna Czapka; Zhigang Rao; Christian Kretzer; Andreas Koeberle; Ulrike Garscha; Simona Pace; Hans-Erik Claesson; Charles N Serhan; Oliver Werz; Jana Gerstmeier
Journal:  FASEB J       Date:  2019-02-08       Impact factor: 5.191

6.  Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations.

Authors:  Svenja D Steinbrink; Carlo Pergola; Ulrike Bühring; Sven George; Julia Metzner; Astrid S Fischer; Ann-Kathrin Häfner; Joanna M Wisniewska; Gerd Geisslinger; Oliver Werz; Dieter Steinhilber; Thorsten J Maier
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

Review 7.  Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.

Authors:  J Martel-Pelletier; D Lajeunesse; P Reboul; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

8.  Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs. Relation to diarrheagenic activity, leukocyte infiltration, and mucosal leukotrienes.

Authors:  K D Rainsford; W E Perkins; P I Stetsko
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

9.  Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs.

Authors:  Olusegun Williams; Benjamin T Houseman; Eric J Kunkel; Brian Aizenstein; Randy Hoffman; Zachary A Knight; Kevan M Shokat
Journal:  Chem Biol       Date:  2010-02-26

10.  Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant.

Authors:  Bruce P Burnett; Alessandra Bitto; Domenica Altavilla; Francesco Squadrito; Robert M Levy; Lakshmi Pillai
Journal:  Mediators Inflamm       Date:  2011-06-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.